TFO Wealth Partners’s NanoViricides NNVC Stock Holding History

TFO Wealth Partners’s Portfolio NNVC Stock Details NNVC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-65	Closed	-$75	–	1041
2023 Q3	$75	Hold	65	–	–	﹤0.01%	1007
2023 Q2	$75	Hold	65	–	–	﹤0.01%	713
2023 Q1	$76	Buy	65 +53	+442%	+$72	﹤0.01%	694
2022 Q4	$382	Sell	12 -53	-82%	-$83	﹤0.01%	521
2022 Q3	$0	Hold	65	–	–	﹤0.01%	373
2022 Q2	$0	Hold	65	–	–	﹤0.01%	504
2022 Q1	$0	Hold	65	–	–	﹤0.01%	151
2021 Q4	$0	Hold	65	–	–	﹤0.01%	177
2021 Q3	$0	Hold	65	–	–	﹤0.01%	170
2021 Q2	$0	Hold	65	–	–	﹤0.01%	155
2021 Q1	$0	Hold	65	–	–	﹤0.01%	173
2020 Q4	$0	Buy	+65	New	+$237	﹤0.01%	140
2020 Q3	–	Sell	-308	Closed	-$2K	–	171
2020 Q2	$2K	Hold	308	–	–	﹤0.01%	125
2020 Q1	$1K	Hold	308	–	–	﹤0.01%	120
2019 Q4	$0	Buy	+308	New	+$696	﹤0.01%	142

Other funds holding NNVC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

CLOS

Compagnie Lombard Odier SCmA 1204 Geneva, Switzerland $9.25B AUM 27.04% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $120B AUM 27.84% 1-Year Est. Return

TFO Wealth Partners's NNVC Position: Q4 2023 in Review

TFO Wealth Partners sold out of NanoViricides (NNVC) in Q4 2023, closing a stake of 65 shares — an estimated $75 sold.

TFO Wealth Partners first reported a position in NNVC in Q4 2019 and held it in 15 quarters. The position peaked at $2K in Q2 2020. 32 funds tracked by Wall St. Rank hold NNVC as of Q4 2023.

TFO Wealth Partners reported no remaining NanoViricides position as of Q4 2023 after selling out during the quarter.
TFO Wealth Partners sold 65 NanoViricides shares in Q4 2023, an estimated $75.
TFO Wealth Partners first reported a position in NanoViricides in Q4 2019 and held it in 15 quarters.
TFO Wealth Partners's NanoViricides position peaked at $2K in Q2 2020.
32 funds tracked by Wall St. Rank held NanoViricides as of Q4 2023.

Based on TFO Wealth Partners's 13F filing for Q4 2023, filed 12 Feb 2024.